Product
Paclitaxel IV
1 clinical trial
1 indication
Indication
Breast CancerClinical trial
A Multi-national,Multi-center, Open-label, Phase 2 Clinical Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of DHP107 (Liporaxel®,Oral Paclitaxel) Compared to IV Paclitaxel in Patients With Recurrent or Metastatic Breast Cancer(OPERA)Status: Completed, Estimated PCD: 2022-12-13